Biomarker: W001-IgE Ragweed, Short

Overview

W001-IgE Ragweed, Short measures serum immunoglobulin E (IgE) antibodies specific to short ragweed pollen, primarily from Ambrosia artemisiifolia. IgE is involved in immediate-type allergic responses, including activation of mast cells and release of inflammatory mediators after allergen exposure. Detectable short-ragweed-specific IgE indicates sensitization and may support a diagnosis of ragweed-associated allergic rhinitis or asthma, but the concentration does not by itself establish symptomatic allergy or predict reaction severity. Short-ragweed-specific IgE is clinically useful when interpreted with exposure history, seasonal symptoms, physical examination, and other allergy testing.

Clinical Use Cases

Support evaluation of seasonal allergic rhinitis, conjunctivitis, or asthma associated with ragweed pollen exposure.
Identify sensitization to short ragweed when skin testing is impractical, contraindicated, or affected by medications.
Help distinguish short-ragweed sensitization from sensitization to other weed pollens.
Guide allergen-avoidance counseling and consideration of allergen-specific immunotherapy when results are clinically concordant.
Support clinical research involving ragweed allergy, allergen immunotherapy, seasonal symptoms, and molecular allergen sensitization.
Assess short-ragweed sensitization alongside component testing, such as IgE to Amb a 1, when cross-reactivity or complex pollen sensitization requires further evaluation.

Specimen Types

Venous whole blood collected for laboratory processing.
Serum separated from venous blood.
Plasma may be accepted by some assay systems, depending on laboratory validation.

Measurement Methods

Automated fluorescence enzyme immunoassay, including ImmunoCAP-type assays.
Other validated quantitative enzyme immunoassays or solid-phase immunoassays.
Historical methods include radioallergosorbent testing and related radioimmunoassays.
Results are commonly reported quantitatively in kUA/L or kU/L and may also be assigned an interpretive class.

Test Preparation and Influencing Factors

No fasting or other special preparation is usually required for an allergy blood test.
Patients should report all medications and supplements. Antihistamines generally do not interfere with serum-specific IgE testing, although they can suppress skin-test responses; medication changes should follow clinician instructions.
Results should be interpreted with the timing, intensity, and geographic relevance of ragweed exposure. Ragweed pollen commonly contributes to late-summer and early-fall seasonal allergy symptoms.
A positive result indicates sensitization, not necessarily clinically relevant symptoms. Some sensitized individuals have no significant allergic disease.
Specific IgE concentrations do not reliably correlate with symptom severity or the severity of a future allergic reaction.
Very high total IgE can cause nonspecific binding and potentially false-positive specific IgE results.
Cross-reactivity with other ragweed species and unrelated pollens may affect interpretation. Short and giant ragweed are not allergenically identical, although substantial cross-reactivity has been reported.
A negative result reduces the likelihood of short-ragweed sensitization but does not absolutely exclude allergy; clinical history and, when appropriate, skin testing remain important.